A

Alterity Therapeutics Limited

D
ATHE
USD
0
(0%)
Market Closed
1.00000
Volume
-0.6
EPS
-
Div Yield
-0.523112
P/E
10,715,031.58
Market Cap
Today
0.0000%
1 Week
-1.626%
1 Month
-16.552%
6 Months
-27.545%
12 Months
-55.515%
Year To Date
-51.600%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news

Thailand's Economy Stumbles as Regional Peers Improve

04.04.2024
Economy news
More
Related Instruments
O
OCX
-0.02
(-0.6515%)
USD
C
CHEK
0.02
(1.1696%)
USD
B
BSGM
(%)
USD
A
AEMD
0.0419
(11.7697%)
USD
N
NBY
-0.0177
(-3.4706%)
USD
V
VSTM
0.105
(3.8674%)
USD
S
SNDX
0.61
(3.387%)
USD
I
ISR
(%)
USD
Z
ZOM
-0.0025
(-1.8939%)
USD
T
TNXP
0.0048
(3.3081%)
USD

Title:
Alterity Therapeutics Limited

Sector:
Healthcare
Industry:
Biotechnology
Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaborations for the treatment of Parkinsonian movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company's lead drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has also advanced a drug candidate for Parkinson's disease and other movement disorders (ATH434). The Group operated in one segment, being researching and developing Parkinsonian and other neurodegenerative disorders.
Do you need help or have a question?
Contact Us